sygnaturediscovery.com

Webbplats analys sygnaturediscovery.com

Sygnature Discovery - Leading Contract Research Organisation

 Genereras på April 06 2026 22:57 PM

Gammal statistik? UPDATERA !

Ställningen är 63/100

SEO Innehåll

Titel

Sygnature Discovery - Leading Contract Research Organisation

Längd : 60

Perfekt, din titel innehåller mellan 10 och 70 tecken.

Beskrivning

Sygnature Discovery is a world-leading integrated drug discovery CRO based in the UK and Canada with headquarters in Nottingham (UK).

Längd : 133

Bra, din metabeskrivning innehåller mellan 70 och 160 tecken.

Nyckelord

Mycket dåligt. Vi har inte lyckats hitta några meta-taggar på din sida. Använd denna meta-tag generator, gratis för att skapa nyckelord.

Og Meta Egenskaper

Bra, din sida drar nytta utav Og.

Egendom Innehåll
locale en_US
type website
title Sygnature Discovery - Leading Contract Research Organisation
description Sygnature Discovery is a world-leading integrated drug discovery CRO based in the UK and Canada with headquarters in Nottingham (UK).
url https://www.sygnaturediscovery.com/
site_name Sygnature
image https://www.sygnaturediscovery.com/wp-content/uploads/2026/02/sygnature-hit-to-lead-team-collaboration-scaled.webp
image:width 2560
image:height 1707
image:type image/webp

Rubriker

H1 H2 H3 H4 H5 H6
1 25 28 137 8 0
  • [H1] Achieving exceptional scientific outcomesthrough connected drug discovery.
  • [H2] World-leading drug discovery solutions, accelerating your compound to the clinic.
  • [H2] We offer deep expertise across the full range of drug discovery solutions.
  • [H2] We deliver world-class scientific expertise and flexible services across every discipline in preclinical discovery.
  • [H2] Integrated Drug Discovery
  • [H2] Computer Aided Drug Design
  • [H2] Protein & Structure
  • [H2] Bioscience
  • [H2] Chemistry
  • [H2] Drug Metabolism and Pharmacokinetics (DMPK)
  • [H2] in vivo Pharmacology
  • [H2] Form and Formulation
  • [H2] We offer specialist expertise across a range of modalities, target classes and therapeutic areas.
  • [H2] Modalities
  • [H2] Target Classes
  • [H2] Therapeutic Areas
  • [H2] World-leading drug discovery
  • [H2] At Sygnature Discovery, we create exceptional scientific outcomes
  • [H2] Reshaping drug discovery by uniting technology, disciplines and talent across Europe and North America
  • [H2] Impact that lasts
  • [H2] Our track record
  • [H2] Trusted by customers worldwide
  • [H2] Interested in joining our team?
  • [H2] News & Resources
  • [H2] Ready to start a conversation?
  • [H2] You're in the right place!
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] in vivo Pharmacology solutions
  • [H3] Featured Resources
  • [H3] Ion channels Ion channels
  • [H3] Featured Resources
  • [H3] Featured Resources Overview
  • [H3] Featured Resources
  • [H3] Categories View all
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] in vivo Pharmacology solutions
  • [H3] Featured Resources
  • [H3] Ion channels Ion channels
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] Categories View all
  • [H3] Featured Resources
  • [H3] From Lead to Pre-Candidate Nomination in 18 Months
  • [H3] Sitryx: Empowering New Ideas
  • [H3] Rapid creation of ideas using generative AI (GenAI) with Iktos Makya
  • [H3] Corcept Therapeutics: Integrated Drug Discovery Collaboration
  • [H3] CellCentric Lead Optimisation Campaign – CCS1477
  • [H3] Fragment-based hit discovery for the epigenetic target, BRD3
  • [H3] Hit Identification to 3 Compounds in the Clinic and 6 Development Candidates
  • [H4] Integrated Drug Discovery
  • [H4] Target Identification & Validation
  • [H4] Hit Identification
  • [H4] Hit-to-Lead
  • [H4] Lead Optimization
  • [H4] STORM Therapeutics: From Lead to Pre-Candidate Nomination in 18 Months
  • [H4] Computer Aided Drug Design
  • [H4] Bioinformatics
  • [H4] Target Analysis
  • [H4] Virtual Screening
  • [H4] Structure Based Drug Design
  • [H4] Generative AI and Machine Learning
  • [H4] Ligand Based Drug Design
  • [H4] Library Design
  • [H4] ADMET Predictions
  • [H4] Informatics
  • [H4] Rapid creation of ideas using generative AI (GenAI) with Iktos Makya
  • [H4] Protein Science and Structural Biology
  • [H4] Protein Expression and Purification
  • [H4] Membrane Proteins
  • [H4] Antibodies and Biotherapeutics
  • [H4] Structural Biology
  • [H4] X-Ray Crystallography
  • [H4] cryo-EM
  • [H4] Macromolecular NMR
  • [H4] Protein Characterization
  • [H4] Protein Mass Spectrometry
  • [H4] FIDA
  • [H4] A Comparison of the Structural Techniques used at Sygnature Discovery: X-ray Crystallography, NMR and Cryo-EM
  • [H4] Bioscience
  • [H4] Cell Line Generation
  • [H4] Assay Development
  • [H4] Electrophysiology
  • [H4] High Throughput Screening
  • [H4] Cell Based Assays
  • [H4] Biochemical Assays
  • [H4] Biophysical Assays
  • [H4] Primary Cells and Tissues
  • [H4] Integrating Hit Finding and Direct-to-Biology to Shorten Time to Development Candidate
  • [H4] Chemistry
  • [H4] Medicinal Chemistry
  • [H4] Synthetic Chemistry
  • [H4] Process & Scale-up Chemistry
  • [H4] NMR-Spectroscopy
  • [H4] Separation Sciences
  • [H4] High Throughput Chemistry
  • [H4] Why Early Process Chemistry Matters?
  • [H4] Drug Metabolism and Pharmacokinetics
  • [H4] Physicochemical Profiling
  • [H4] Chemical & Metabolic Stability
  • [H4] Permeability
  • [H4] Tissue Binding
  • [H4] Drug-Drug Interactions
  • [H4] Biotransformation
  • [H4] Analytical Method Development & Bioanalysis
  • [H4] in vivo Pharmacokinetic & Pharmacodynamic Studies
  • [H4] PK & PK/PD Modelling and Simulation
  • [H4] DMPK Consultancy
  • [H4] Dedicated DMPK for Bifunctional Degraders: A Flexible Approach for Flexible Molecules
  • [H4] in vivo Pharmacology
  • [H4] CNS/Pain Models
  • [H4] Metabolic Disease Models
  • [H4] Inflammation & Immunology Models
  • [H4] Oncology Models
  • [H4] Non-Regulatory Toxicology
  • [H4] in vivo Pharmacokinetics
  • [H4] ex vivo Tissue Analysis
  • [H4] Evaluation of Two Novel Compounds Compared to Methadone on Morphine Withdrawal in a Rat Model of Physical dependence
  • [H4] Form & Formulation
  • [H4] Early Clinical Formulation
  • [H4] Solid Form Analysis
  • [H4] Salt and Co-Crystal Screening
  • [H4] Polymorph Screening
  • [H4] Pre-Clinical Formulation
  • [H4] Assessing Lypoprotectant Effect on Particle Size of Liposomal Systems
  • [H4] Modalities
  • [H4] Small Molecules
  • [H4] Peptides
  • [H4] Targeted protein degradation
  • [H4] ADCs
  • [H4] Biologics
  • [H4] Next-Generation Antibody Drug Conjugates
  • [H4] Ion Channels
  • [H4] GABAA Receptors
  • [H4] NMDA Receptors
  • [H4] Glycine Receptors
  • [H4] Nicotinic Receptors
  • [H4] TRP Channels
  • [H4] Sodium Channels
  • [H4] Calcium Channels
  • [H4] Potassium Channels
  • [H4] Chloride Channels
  • [H4] TMEM175
  • [H4] Delivering Custom Cell-Based Tools for Drug Discovery
  • [H4] Sygnature Discovery Successfully Provides Clinical Candidate to Corcept Therapeutics
  • [H4] Therapeutic Areas
  • [H4] Oncology and Immuno-Oncology
  • [H4] Inflammation and Immunology
  • [H4] Neuroscience
  • [H4] Metabolic Diseases
  • [H4] CellCentric Lead Optimisation Campaign - CCS1477
  • [H4] Blog
  • [H4] Webinars & Podcasts
  • [H4] Posters
  • [H4] Journal Papers
  • [H4] Technical Notes
  • [H4] Case Studies
  • [H4] eBooks
  • [H4] Protocols
  • [H4] News
  • [H4] Events
  • [H4] About Sygnature
  • [H4] Meet our Team
  • [H4] Careers
  • [H4] Integrated Drug Discovery
  • [H4] Target Identification & Validation
  • [H4] Hit Identification
  • [H4] Hit-to-Lead
  • [H4] Lead Optimization
  • [H4] STORM Therapeutics: From Lead to Pre-Candidate Nomination in 18 Months
  • [H4] Modalities
  • [H4] Small Molecules
  • [H4] Peptides
  • [H4] Targeted protein degradation
  • [H4] ADCs
  • [H4] Biologics
  • [H4] Next-Generation Antibody Drug Conjugates
  • [H4] Therapeutic Areas
  • [H4] Oncology and Immuno-Oncology
  • [H4] Inflammation and Immunology
  • [H4] Neuroscience
  • [H4] Metabolic Diseases
  • [H4] CellCentric Lead Optimisation Campaign - CCS1477
  • [H4] About Sygnature
  • [H4] Meet our Team
  • [H4] Careers
  • [H4] UK (Nottingham)
  • [H5] Our Office Locations
  • [H5] Drug Discovery
  • [H5] modalities
  • [H5] Target Classes
  • [H5] Scientific solutions
  • [H5] Therapeutic Areas
  • [H5] Website
  • [H5] Resource Hub

Bilder

Vi hittade 77 bilder på denna webbsida.

38 alt attribut är tomma eller saknas. Lägg till alternativ text så att sökmotorer enklare kan förstå innehållet i dina bilder.

Text/HTML Ratio

Ratio : 26%

Idealisk! Den här sidans text till HTML-kod förhållande är mellan 25 och 70 procent.

Flash

Perfekt, inga Flash-innehåll har upptäckts på denna sida.

Iframe

Synd, du har Iframes på webbsidorna vilket innebär att innehållet i en Iframe inte kan indexeras.

URL Rewrite

Bra. Dina adressfält ser bra ut!

Understreck i URLen

Vi har upptäckt understreck i din webbadress. Du bör hellre använda bindestreck för att optimera din SEO.

In-page länkar

Vi hittade totalt 70 länkar inklusive 4 länk(ar) till filer

Anchor Typ Juice
Explore the STORM Therapeutics case study Interna Passing Juice
Contact Interna Passing Juice
Contact us Interna Passing Juice
Get in touch Interna Passing Juice
What we do Interna Passing Juice
Learn more about Drug Discovery Interna Passing Juice
Learn more about Scientific Solutions Interna Passing Juice
Explore CADD Interna Passing Juice
Explore Protein and Structure Interna Passing Juice
Explore Bioscience Interna Passing Juice
Explore Chemistry Interna Passing Juice
Explore DMPK Interna Passing Juice
Explore in vivo Pharmacology Interna Passing Juice
Explore Form and Formulation Interna Passing Juice
Discover our Modalities Interna Passing Juice
Learn more about Target Classes Interna Passing Juice
Explore our Therapeutic Areas Interna Passing Juice
At Sygnature Discovery, we create exceptional scientific outcomes Interna Passing Juice
Reshaping drug discovery by uniting technology, disciplines and talent across Europe and North America Interna Passing Juice
Impact that lasts Interna Passing Juice
Learn more Interna Passing Juice
Read the case study Interna Passing Juice
Read the case study Interna Passing Juice
Read the case study Interna Passing Juice
Read the case study Interna Passing Juice
Read the case study Interna Passing Juice
Read the case study Interna Passing Juice
View our Careers Page Interna Passing Juice
Bringing Connected Drug Discovery Together Under One Name Interna Passing Juice
Dr Simon Hirst awarded prestigious honorary Doctorate from the University of Nottingham Interna Passing Juice
Sygnature Discovery Completes Major Enhancement of High-Throughput Chemistry Facilities Following £1 Million Investment Interna Passing Juice
Sygnature Discovery boosts growth of its in vivo Pharmacology business with appointment of new Vice President Interna Passing Juice
Sygnature Discovery Appoints New Chief Commercial Officer to Drive Next Phase of Business Growth Interna Passing Juice
Sygnature Discovery appoints Rick Davies to spearhead growth as Director of its UK Protein Sciences and Structural Biology business (formerly, Peak Proteins) Interna Passing Juice
View all locations Interna Passing Juice
Target Identification & Validation Interna Passing Juice
Hit Identification Interna Passing Juice
Hit-to-Lead Interna Passing Juice
Lead Optimization Interna Passing Juice
Small Molecules Interna Passing Juice
Peptides Interna Passing Juice
Targeted Protein Degradation Interna Passing Juice
ADCs Interna Passing Juice
Biologics Interna Passing Juice
Ion channels Interna Passing Juice
GPCRs Interna Passing Juice
Transporters Interna Passing Juice
Oncology Interna Passing Juice
Inflammation and Immunology Interna Passing Juice
Neuroscience Interna Passing Juice
Metabolic Diseases Interna Passing Juice
Meet our Team Interna Passing Juice
Working with us Interna Passing Juice
Environmental, social, governance Interna Passing Juice
Blog Interna Passing Juice
Webinars & Podcasts Interna Passing Juice
Posters Interna Passing Juice
Journal Papers Interna Passing Juice
Technical Notes Interna Passing Juice
eBooks Interna Passing Juice
Protocols Interna Passing Juice
Case Studies Interna Passing Juice
News Interna Passing Juice
Events Interna Passing Juice
Privacy Policy Interna Passing Juice
Cookie Policy Interna Passing Juice
Website terms of use Interna Passing Juice
Modern Slavery Statement Interna Passing Juice
Supplier Code of Conduct Interna Passing Juice
Website Design Agency Externa Passing Juice

SEO Nyckelord

Nyckelord Moln

sygnature design from solutions drug chemistry discovery integrated target expertise

Nyckelord Konsistens

Nyckelord Innehåll Titel Nyckelord Beskrivning Rubriker
discovery 91
drug 68
sygnature 33
integrated 26
expertise 25

Användbarhet

Url

Domän : sygnaturediscovery.com

Längd : 22

Favikon

Bra, din webbplats har en favicon.

Utskriftbart

Bra. Vi hittade CSS för utskrifter.

Språk

Bra. Ditt angivna språk är en.

Dublin Core

Denna sida drar inte nytta utav Dublin Core.

Dokument

Doctype

HTML 5

Encoding

Perfekt. Din deklarerade teckenuppsättning är UTF-8.

W3C Validity

Errors : 0

Varningar : 0

E-post Sekretess

Varning! Minst en e-postadress har påträffats i klartext. Använd gratis antispam skydd för att dölja e-post från spammare.

Föråldrad HTML

Bra! Vi har inte hittat några föråldrad HTML taggar i din HTML.

Hastighets Tips

Utmärkt, din webbplats använder inga nästlade tabeller.
Synd, din webbplats använder sig utav inline stilar.
Synd, din webbplats har för många CSS-filer (fler än 4 stycken).
Synd, din webbplats har för många JS filer (fler än 6 stycken).
Perfekt, din webbplats utnyttjar gzip.

Mobil

Mobiloptimering

Apple Ikon
Meta Viewport Tagg
Flash innehåll

Optimering

XML Sitemap

Bra, din webbplats har en XML sitemap.

https://www.sygnaturediscovery.com/sitemap_index.xml

Robots.txt

https://sygnaturediscovery.com/robots.txt

Bra, din webbplats har en robots.txt fil.

Analytics

Saknas

Vi hittade inte någon analysverktyg på din webbplats.

Webbanalys program kan mäta besökare på din webbplats. Du bör ha minst ett analysverktyg installerat, men det kan också vara en bra ide att installera två för att dubbelkolla uppgifterna.

PageSpeed Insights

Enhet
Kategorier

Free SEO Testing Tool

Free SEO Testing Tool är en fri SEO verktyg som hjälper dig att analysera din webbplats